Alcon (ALC) FFO


ALC Alcon Inc ALC
71 GF Score
Price $67.93
GF Value $90.79
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alcon FFO?

FFO (Funds from operations) only applies to REITs.

ALC
71GF Score
Alcon Inc ALC
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alcon (ALC) Overvalued in 2026?

Based on GuruFocus' analysis, Alcon stock appears to be undervalued. The current stock price of $67.93 is trading 25.2% below its estimated GF Value™ of $90.79. GuruFocus considers Alcon to be Modestly Undervalued.

Key valuation signals for ALC:

  • FFO:
  • GF Value™: $90.79 vs. price of $67.93 (25.2% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the ALC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alcon Business Description

Address Chemin de Blandonnet 8, Vernier, Geneva, CHE, 1214
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
71GF Score

Get the complete analysis for ALC

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$67.93
Price
$90.79
GF Value